These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23767960)

  • 21. Preparation and Evaluation of the Fully Humanized Monoclonal Antibody GD-mAb Against Respiratory Syncytial Virus.
    Tian P; Wang Y; Liu H; Yang Y; Wu X; Wei H; Chen T
    Front Cell Infect Microbiol; 2019; 9():275. PubMed ID: 31417879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutralization Assay for Chikungunya Virus Infection: Plaque Reduction Neutralization Test.
    Azami NA; Moi ML; Takasaki T
    Methods Mol Biol; 2016; 1426():273-82. PubMed ID: 27233280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and application of a higher throughput RSV plaque assay by immunofluorescent imaging.
    Wen Z; Citron M; Bett AJ; Espeseth AS; Vora KA; Zhang L; DiStefano DJ
    J Virol Methods; 2019 Jan; 263():88-95. PubMed ID: 30381239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the respiratory syncytial virus G-directed neutralizing antibody response in the human airway epithelial cell model.
    Kishko M; Catalan J; Swanson K; DiNapoli J; Wei CJ; Delagrave S; Chivukula S; Zhang L
    Virology; 2020 Nov; 550():21-26. PubMed ID: 32866728
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children.
    McFarland EJ; Karron RA; Muresan P; Cunningham CK; Perlowski C; Libous J; Oliva J; Jean-Philippe P; Moye J; Schappell E; Barr E; Rexroad V; Fearn L; Cielo M; Wiznia A; Deville JG; Yang L; Luongo C; Collins PL; Buchholz UJ
    J Infect Dis; 2020 Jun; 221(12):2050-2059. PubMed ID: 32006006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of beta-galactosidase by recombinant respiratory syncytial viruses for microneutralization assay.
    Cheng X; Munoz MG; Zhou H; Jin H
    J Virol Methods; 2002 Sep; 105(2):287-96. PubMed ID: 12270661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus.
    Shinoff JJ; O'Brien KL; Thumar B; Shaw JB; Reid R; Hua W; Santosham M; Karron RA
    J Infect Dis; 2008 Oct; 198(7):1007-15. PubMed ID: 18702606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of complement in neutralization of respiratory syncytial virus.
    Yoder SM; Zhu Y; Ikizler MR; Wright PF
    J Med Virol; 2004 Apr; 72(4):688-94. PubMed ID: 14981775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies in lymphocyte supernatants can distinguish between neutralising antibodies induced by RSV vaccination and pre-existing antibodies induced by natural infection.
    Gerretsen HE; Capone S; Vitelli A; Reyes LS; Thompson A; Jones C; Green CA; Pollard AJ; Sande CJ
    Vaccine; 2018 Nov; 36(46):6988-6994. PubMed ID: 30318168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel high-throughput vaccinia virus neutralization assay and preexisting immunity in populations from different geographic regions in China.
    Liu Q; Huang W; Nie J; Zhu R; Gao D; Song A; Meng S; Xu X; Wang Y
    PLoS One; 2012; 7(3):e33392. PubMed ID: 22438922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies.
    Piedra PA; Jewell AM; Cron SG; Atmar RL; Glezen WP
    Vaccine; 2003 Jul; 21(24):3479-82. PubMed ID: 12850364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An efficient, reproducible and accurate RT-qPCR based method to determine mumps specific neutralizing antibody.
    Sikazwe CT; Levy A; Speers D; Smith DW
    J Virol Methods; 2020 Mar; 277():113817. PubMed ID: 31911119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and Significance of Substitutions in the Fusion Protein of Respiratory Syncytial Virus Resulting in Neutralization Escape From Antibody MEDI8897.
    Zhu Q; Lu B; McTamney P; Palaszynski S; Diallo S; Ren K; Ulbrandt ND; Kallewaard N; Wang W; Fernandes F; Wong S; Svabek C; Moldt B; Esser MT; Jing H; Suzich JA
    J Infect Dis; 2018 Jul; 218(4):572-580. PubMed ID: 29617879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virus replicon particle based Chikungunya virus neutralization assay using Gaussia luciferase as readout.
    Gläsker S; Lulla A; Lulla V; Couderc T; Drexler JF; Liljeström P; Lecuit M; Drosten C; Merits A; Kümmerer BM
    Virol J; 2013 Jul; 10():235. PubMed ID: 23855906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new real-time RT-qPCR assay for the detection, subtyping and quantification of human respiratory syncytial viruses positive- and negative-sense RNAs.
    Essaidi-Laziosi M; Lyon M; Mamin A; Fernandes Rocha M; Kaiser L; Tapparel C
    J Virol Methods; 2016 Sep; 235():9-14. PubMed ID: 27180039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Susceptibilities of Respiratory Syncytial Virus to Nucleolin Receptor Blocking and Antibody Neutralization are Dependent upon the Method of Virus Purification.
    Bilawchuk LM; Griffiths CD; Jensen LD; Elawar F; Marchant DJ
    Viruses; 2017 Aug; 9(8):. PubMed ID: 28771197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RSV neutralization assays - Use in immune response assessment.
    Raghunandan R; Higgins D; Hosken N
    Vaccine; 2021 Jul; 39(33):4591-4597. PubMed ID: 34244007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virus-Specific Antibody, Viral Load, and Disease Severity in Respiratory Syncytial Virus Infection.
    Walsh EE; Wang L; Falsey AR; Qiu X; Corbett A; Holden-Wiltse J; Mariani TJ; Topham DJ; Caserta MT
    J Infect Dis; 2018 Jun; 218(2):208-217. PubMed ID: 29546402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Alterations to the CX3C Motif and Secreted Form of Human Respiratory Syncytial Virus (RSV) G Protein on Immune Responses to a Parainfluenza Virus Vector Expressing the RSV G Protein.
    Liang B; Kabatova B; Kabat J; Dorward DW; Liu X; Surman S; Liu X; Moseman AP; Buchholz UJ; Collins PL; Munir S
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.